On 17 January 2026, the Board of the Egyptian Company for Medical Investments (ECMI) held its first meeting of the year to discuss key strategic priorities and review business plans for the upcoming period.

The meeting included an in-depth presentation on the Egyptian Pharmaceutical Trading Company’s strategy and operational plan for the current year, with discussions focusing on performance objectives, growth opportunities, and strengthening collaboration between the two entities.

The meeting was chaired by Dr. Osama Abdelbaset, Chairman and CEO of ECMI.

• Board members in attendance included:

Prof. Dr. Ali Awni

Mr. Ayman Ezzat Abdellatif

Mr. Mohanad T. Khaled

Mrs. Engy Fayez

• From ECMI executive management:

Dr. Yasser Nour – Chief Commercial Officer (CCO)

Mrs. Shaimaa El Kholy – Chief Human Resources Officer (CHRO)

Mr. Ihab Siam – Chief Supply Chain Officer (CSCO)

Mr. Motaz Said – Corporate Finance Manager

• From the Egyptian Pharmaceutical Trading Company:

Dr. Aboul Fotouh Al-Tawil – Chairman and CEO

Dr. Walid Saeda – Chief Supply Chain Officer (CSCO)

Dr. Ehab El Atabany – Chief Commercial Officer (CCO)

Mr. Islam El Zayat – Legal Counsellor

The meeting reflects ECMI’s commitment to effective governance, strategic alignment, and driving sustainable growth across its affiliated companies.